Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

An interview with Franco Negron
In this interview, we spoke with Franco Negron, CEO of Simtra, about how the company is advancing its position as a premier CDMO for sterile injectables while preparing for the next wave of complex biologics. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

NanoImaging Services, Proteos Combine as TrueCourse Biosciences; Gottler Named CEO
Tuesday, September 22, 2026
NanoImaging Services and Proteos have combined under the name TrueCourse Biosciences, creating a U.S.-based contract research organization focused on ... read more
Kincell Bio, Cellipont Bioservices Merge to Form Kincellis Advanced Therapies
Tuesday, September 22, 2026
Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies, a U.S.-based contract development and ... read more
Gaelic and Athlone to Launch Dual-Source Antibiotic Supply Strategy
Monday, September 21, 2026
Gaelic Laboratories and Athlone Laboratories have aligned their manufacturing processes to offer customers a dual-source supply of oral beta-lactam ... read more
mAbxience, Sandoz Partner on Emicizumab Biosimilar for Hemophilia A
Monday, September 21, 2026
mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed biosimilar version of ... read more
Made Scientific Buys 85,000-Square-Foot Pennsylvania Cell-Therapy Plant
Monday, September 21, 2026
Made Scientific has acquired an 85,000-square-foot cell-therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience, ... read more